These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17069522)

  • 1. Mathematical modeling of cancer progression and response to chemotherapy.
    Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
    Ribeiro D; Pinto JM
    Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis testing via integrated computer modeling and digital fluorescence microscopy.
    Gardner MK; Odde DJ; Bloom K
    Methods; 2007 Feb; 41(2):232-7. PubMed ID: 17189865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
    Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
    IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints.
    Mukherjee A; Majumder D
    Biosystems; 2008 Jan; 91(1):108-16. PubMed ID: 17889991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical and numerical analysis for a model of growing metastatic tumors.
    Barbolosi D; Benabdallah A; Hubert F; Verga F
    Math Biosci; 2009 Mar; 218(1):1-14. PubMed ID: 19121638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic origin of drug resistance in neoplasms: implications for systemic therapy.
    Goldie JH; Coldman AJ
    Cancer Res; 1984 Sep; 44(9):3643-53. PubMed ID: 6744284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.
    de Pillis LG; Gu W; Fister KR; Head T; Maples K; Murugan A; Neal T; Yoshida K
    Math Biosci; 2007 Sep; 209(1):292-315. PubMed ID: 17306310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD; Ismael G; Lago LD; Awada A
    Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?
    Kraljevic S; Sedic M; Scott M; Gehrig P; Schlapbach R; Pavelic K
    Cancer Treat Rev; 2006 Dec; 32(8):619-29. PubMed ID: 17069979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modeling for novel cancer drug discovery and development.
    Zhang P; Brusic V
    Expert Opin Drug Discov; 2014 Oct; 9(10):1133-50. PubMed ID: 25062617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genomic markers and anticancer chemotherapy].
    Nishiyama M
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can systems pathology help us personalize cancer therapy?
    Faratian D; Langdon SP; Harrison DJ
    Discov Med; 2009 Aug; 8(41):81-6. PubMed ID: 19788873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A data integration approach for cell cycle analysis oriented to model simulation in systems biology.
    Alfieri R; Merelli I; Mosca E; Milanesi L
    BMC Syst Biol; 2007 Aug; 1():35. PubMed ID: 17678529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical models of cancer stem cells.
    Michor F
    J Clin Oncol; 2008 Jun; 26(17):2854-61. PubMed ID: 18539964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
    Ledzewicz U; Schättler H
    Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of cell biology, pharmacological modeling and statistical analysis: part I: cell biology and PK/PD in the Oncology paradigm.
    Ananthakrishnan R; Menon S
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):153-69. PubMed ID: 22118941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.